Entrectinib

Red

Brand Name(s):

Indication:NTRK fusion +ve solid tumours in adults and children 12 years and older

Rationale:1,2,8

Considered:Oct-20

Review Date:Oct-25

Comments:
NICE TA644 recommends as an option to treat NTRK fusion +ve solid tumours in adults and children 12 years and older in disease that is locally advanced/metastatic and not for surgery, in patients that have not had an NTRK inhibitor